Nine Masts Capital’s TELA Bio TELA Stock Holding History

Nine Masts Capital’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,486	Closed	-$19.5K	–	307
2025 Q4	$19.5K	Buy	+16,486	New	+$20.9K	﹤0.01%	111

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Nine Masts Capital's TELA Position: Q1 2026 in Review

Nine Masts Capital sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 16,486 shares — an estimated $19.5K sold.

Nine Masts Capital first reported a position in TELA in Q4 2025 and held it in 1 quarter. The position peaked at $19.5K in Q4 2025. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

Nine Masts Capital reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
Nine Masts Capital sold 16,486 TELA Bio shares in Q1 2026, an estimated $19.5K.
Nine Masts Capital first reported a position in TELA Bio in Q4 2025 and held it in 1 quarter.
Nine Masts Capital's TELA Bio position peaked at $19.5K in Q4 2025.
36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.